BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scarpini S, Morigi F, Betti L, Dondi A, Biagi C, Lanari M. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice. Vaccines (Basel) 2021;9:551. [PMID: 34070277 DOI: 10.3390/vaccines9060551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanimura K, Uchida A, Imafuku H, Tairaku S, Fujioka K, Morioka I, Yamada H. The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection. Int J Mol Sci 2021;22:13487. [PMID: 34948284 DOI: 10.3390/ijms222413487] [Reference Citation Analysis]
2 Majewska A, Mlynarczyk-Bonikowska B. 40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs? Int J Mol Sci 2022;23:3431. [PMID: 35408788 DOI: 10.3390/ijms23073431] [Reference Citation Analysis]
3 Tripp RA. Advances in Vaccine Development. Vaccines (Basel) 2021;9:1036. [PMID: 34579273 DOI: 10.3390/vaccines9091036] [Reference Citation Analysis]
4 El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation. Front Immunol 2021;12:730765. [PMID: 34566995 DOI: 10.3389/fimmu.2021.730765] [Reference Citation Analysis]
5 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
6 Niculescu AG, Bîrcă AC, Grumezescu AM. New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery. Pharmaceutics 2021;13:2053. [PMID: 34959335 DOI: 10.3390/pharmaceutics13122053] [Reference Citation Analysis]
7 Hong J, Wei D, Zhong L, Wu Q, Chen K, Zhang W, Yang Y, Chen J, Xia N, Zhang X, Chen Y. Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells. Front Immunol 2022;13:920467. [PMID: 35711430 DOI: 10.3389/fimmu.2022.920467] [Reference Citation Analysis]